DR. ABDULELAH ALHAWSAWI

CEO Noor Diagnostic & Discovery - Riyadh

Dr. Abdulelah Alhawsawi, CEO Noor Diagnostic & Discovery, Riyadh

Dr. Abdulelah Alhawsawi, is the CEO of Noor Dx – the Kingdom’s first genomic and bioinformatics company. Noor Dx’s mission is to use individual genomic information to screen, diagnose and empower clinicians and patients to make effective and personalized health care decisions in treatment and prognosis, primarily in the following specialties: Oncology, pharmacology / companion diagnostics, pediatric inherited disorders, prenatal genetics, and Infectious diseases.

Dr. Alhawsawi the Former – founding Director General of the Saudi Patient Safety Center (SPSC), and MOH Advisor on Patient Safety. He led the efforts to establishing SPSC as a WHO Collaborating Center for patient safety policies and strategies (1 of only 5 WHOcc worldwide in this field). He holds Dual Certified Boards (American – Canadian) of general surgery with sub-specialty in Transplant and Hepatobiliary Surgery.

He is a consultant to several national and international quality and safety organizations and recently became a board member and Vice President of the Global Sepsis Alliance (GSA) as well as an adviser to American Health Information Management Association (AHIMA) international. He was part of the Expert Panel on the 3rd Global Patient Safety Challenge of the WHO and chaired the Organizing Committee for the 4th Global Ministerial Summit on Patient Safety in Jeddah, Saudi Arabia in 2019. Dr. Alhawsawi has helped introduce Patient Safety as a G20 priority in the 2020 G20 of Saudi Arabia.
Currently, Dr. Alhawsawi is part of the WHO’s Global Patient Safety Action Plan Taskforce.

Social Share

× How can I help you?